Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
US9272016B2 · kind B2 · utility
0Cited by
7References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2013 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Jul 10, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/713
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of reducing a level of a target mRNA in a well-differentiated airway epithelial cell by contacting the cell with a sensitizing agent followed by contacting the cell with a therapeutic RNAi agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.